Study to Assess Safety,Tolerability,Efficacy of PM01183 and Atezolizumab in Patients w/ Advanced Small Cell Lung Cancer.

Clinical trial NCT04253145 · UNKNOWN

Trial details

NCT number: NCT04253145
Sponsor: Fundacion Oncosur
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Carcinoma, Small Cell Lung

Start date: 2019-12-13
Primary completion: 2025-05-01
Enrollment: 184

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.